Precigen, Inc.

US$4.47As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PGENHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (16.15%)
Div yield —
ROE 38.84%
Biotechnology
Beta (5Y) 0.98
PE TTM 65.92
TSR TTM 7.97%
Mkt cap US$1.603B
ROIC 27.79%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$4.53
1.41%
62.17%
Hold 12|9|7|9|11
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.06
0.06
0.06
0.06
26.09%
16.87%
15.53%
15.90%
Revenue$M
138.4
142.5
138.6
136.9
(2.26%)
3.48%
(0.90%)
(0.12%)
Peers (US$1.603B)
Cap (US$)
PE
1.672B
5.690x
Capital
TTM
5Y
10Y
Leveragex
2.515
0.394
0.309
EBIT/Intx
1.067
2.880
2.294
Own earn%
(33.64)
(175.73)
(148.78)
Sh yield%
54.05
17.16
14.39
Owners
Insiders/Inst%
7.91
33.91
Short interest%
3.82
SBC / revenue%
1.31
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
26–35
$1 testx
−0.4
Incr. ROIC%
7